Member Analysis : Small Cap Stocks and Penny Stocks For Big Returns

ChromaDex Focuses on Clinical Data, Learns from Sambazon's Mistakes With Acai

Published: Monday, May 27, 2013 6:52 PM PDT

Print Email

ChromaDex Corporation (OTCQB: CDXC) identifies naturally-occuring compounds with escalating interest for human health, researches their clinical effectiveness, and then sells manufacturing and claim rights to larger companies. In the past three years, ChromaDex completed human clinical studies and acquired substantially all patents and intellectual property for a blueberry compound, pterostilbene, and then sold rights to this compound for $6.2 million. Much like its predecessor in the rapidly growing nutraceutical...

Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

Sollensys Draws Interest as Touch Screen Sector Grows

By Jun Suh

Published: Tuesday, April 9, 2013 12:05 PM PDT

Print Email

Trading activity in this stock has been accelerating as awareness grows.

Symbol(s): SOLS
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

South Korea's Sollensys Begins Fresh Trading on U.S. Stock Market

By Jun Suh

Published: Saturday, March 2, 2013 3:43 PM PST

Print Email

With a dual business model of in-house manufacturing plus franchised factories, this young company from Asia enters the fast-growing market for mobile device display components.

Symbol(s): SOLS
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

6 Comment(s)

Rating N/A

Substantial Update for Sunesis Pharmaceuticals, Inc. MUST SEE

By phillips.hogan

Published: Wednesday, September 12, 2012 4:29 AM PDT

Print Email

We simply wanted to share this service with everybody. This website has an article with extensive info of fast moving small cap stocks.http://xolonline.biz/SNSS...

Symbol(s): SNSS
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

ACTC is very bad. This is the reason.

By townsend.orme

Published: Tuesday, September 11, 2012 11:13 PM PDT

Print Email

Has everybody read in detail the articles being produced? Awesome details that will help any investor or trader. http://xols.biz/ACTC...

Symbol(s): ACTC
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

FRO may be ended. Find out why.

By sharp.spicer

Published: Tuesday, September 11, 2012 11:07 PM PDT

Print Email

Has anyone taken a look at the articles being presented? Incredible info that will assist any investor or trader. http://xolnow.biz/FRO...

Symbol(s): FRO
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

Should you sidestep BYD? Discover why.

By vaughan.aranda

Published: Tuesday, September 11, 2012 10:45 PM PDT

Print Email

Has someone checked out the articles being published? Fascinating details that will help any investor or trader. http://xtalstore.biz/BYD...

Symbol(s): BYD
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating N/A

Could Computing - In the Eye of The Storm

By mine2capital

Published: Monday, August 6, 2012 4:33 PM PDT

Print Email

MULTI-BILLION DOLLAR MARKET – NOW IN NASCENT STAGEForrester Research predicts that the global Cloud Computing market will growfrom $ 40.7B in 2011 to $ 241B by 2020. Both Gartner and Merrill Lynch’s (Bankof America Merrill Lynch’s) research predict the Cloud Computing market will beworth $ 150B - $ 160B by 2013. Forrester’s prediction stands at a more modestbelow $ 100B USD for 2013. Most market forecasts are that the total cloud servicesmarket will reach approximately $ 45-50B in revenue by 2013/2014, including...

Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Medium

0 Comment(s)

Rating 4

Room to Grow for Entergy Corp

By investingdaily

Published: Friday, July 13, 2012 8:56 AM PDT

Print Email

By: Roger Conrad On Jun. 20, 2012, Standard & Poor’s boosted Entergy Corp’s (NYSE: ETR) credit outlook to “stable.” The rater noted “sustained and consistent improvement” at regulated operations and “effective management” of nuclear plant relicensing. That’s long overdue recognition. But the likely catalyst for the upgrade was the late-May decision by the Nuclear Regulatory Commission (NRC) to relicense the Pilgrim plant in Massachusetts for another 20 years. Combined with the appointment of a more conciliatory...

Symbol(s): ETR, ITC
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	Low

0 Comment(s)

Rating N/A

Gold Exploration Penny Stock

By John D Kolb

Published: Monday, June 25, 2012 6:48 PM PDT

Print Email

New stock report on an exciting opportunity in a gold exploration penny stock follow the link below to view my report.http://www.pennystock-blog.com/2012/06/brigus-gold-corp-brd-gold-penny-stock.html...

Symbol(s): BRD
Action	Recommendation	Timeframe	Risk
No Action	Buy	Mid-Term	High

0 Comment(s)

Rating N/A